Biopharma organisations need to improve their chances of successfully launching new drugs. Poor organisational outcomes create a range of issues, which can be supported through Acorn AI's operational analytics in Intellignet Trials.
This provides large sponsors with insights and out-of-the-box solutions, through a range of models and analytics, including study design, study feasibility and performance analytics.
This proposes targeted innovations can be made, through the accessibility of data and analytics from Acorn AI.
This whitepaper discusses fit-for-purpse data sources, which support the challenges faced in the Biopharma industry.